Indix Combi

Indapamide, the active ingredient in Indix Combi, is a thiazide‑like diuretic and Perindopril Tosilate is an ACE inhibitor presented as a tablet for oral use. It is used to lower elevated blood pressure in adults with essential hypertension. GNH USA supplies Indix Combi as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Indix Combi combines a thiazide‑like diuretic and an ACE inhibitor to manage high blood pressure. - Hypertension: reduces systolic and diastolic pressure in adults with essential hypertension, improving cardiovascular risk profile.

Adverse reactions may occur with any antihypertensive combination therapy.

Common Side Effects: - Dizziness: transient light‑headedness, especially after the first dose. - Cough: dry, persistent throat irritation. - Headache: mild to moderate intensity. - Increased urination: due to diuretic action. - Electrolyte imbalance: mild changes in potassium or sodium levels.

Serious or Rare Side Effects: - Angioedema: swelling of face, lips, or airway requiring emergency care. - Severe hypotension: marked drop in blood pressure causing fainting. - Renal impairment: sudden decrease in kidney function, especially in patients with pre‑existing disease. - Hyperkalemia: elevated potassium that can affect heart rhythm. - Pancreatitis: rare inflammation of the pancreas.

Patients should be monitored for safety considerations before and during therapy. - Renal function: assess serum creatinine and eGFR regularly. - Electrolytes: monitor potassium and sodium levels, especially when combined with other diuretics. - Hepatic impairment: use with caution in severe liver disease. - Elderly patients: start at lower doses and observe for orthostatic symptoms. - Pregnancy and lactation: safety not established; avoid unless clearly needed. - Store at room temperature: keep in the original container, protect from moisture and direct sunlight.

Indix Combi may interact with several medicines, requiring attention to avoid adverse outcomes.

Major Interactions (Avoid): - Potassium‑sparing diuretics: risk of hyperkalemia. - Aliskiren (in diabetes): additive renal risk. - Lithium: increased lithium levels and toxicity. - NSAIDs: may blunt antihypertensive effect and impair renal function. - Other ACE inhibitors or ARBs: excessive hypotension and renal dysfunction.

Moderate Interactions (Monitor Closely): - Thiazide‑type diuretics: cumulative electrolyte disturbances. - Beta‑blockers: additive blood‑pressure lowering. - Diuretics with glucocorticoids: possible potassium loss. - Antidiabetic agents: may require dose adjustment due to improved glycemic control.